Currently released so far... 51122 / 251,287

### Articles

Brazil Sri Lanka United Kingdom Sweden 00. Editorial United States Latin America Egypt Jordan Yemen Thailand

### Browse latest releases

2010/11 2010/12 2011/01 2011/02 2011/03 2011/04 2011/05 2011/06 2011/07 2011/08
2010/11/28 2010/11/29 2010/11/30
2010/12/01 2010/12/02 2010/12/03 2010/12/04 2010/12/05 2010/12/06 2010/12/07 2010/12/08 2010/12/09 2010/12/10 2010/12/11 2010/12/12 2010/12/13 2010/12/14 2010/12/15 2010/12/16 2010/12/17 2010/12/18 2010/12/19 2010/12/20 2010/12/21 2010/12/22 2010/12/23 2010/12/24 2010/12/25 2010/12/26 2010/12/27 2010/12/28 2010/12/29 2010/12/30
2011/01/01 2011/01/02 2011/01/04 2011/01/05 2011/01/07 2011/01/09 2011/01/11 2011/01/12 2011/01/13 2011/01/14 2011/01/15 2011/01/16 2011/01/17 2011/01/18 2011/01/19 2011/01/20 2011/01/21 2011/01/22 2011/01/23 2011/01/24 2011/01/25 2011/01/26 2011/01/27 2011/01/28 2011/01/29 2011/01/30 2011/01/31
2011/02/01 2011/02/02 2011/02/03 2011/02/04 2011/02/05 2011/02/06 2011/02/07 2011/02/08 2011/02/09 2011/02/10 2011/02/11 2011/02/12 2011/02/13 2011/02/14 2011/02/15 2011/02/16 2011/02/17 2011/02/18 2011/02/19 2011/02/20 2011/02/21 2011/02/22 2011/02/23 2011/02/24 2011/02/25 2011/02/26 2011/02/27 2011/02/28
2011/03/01 2011/03/02 2011/03/03 2011/03/04 2011/03/05 2011/03/06 2011/03/07 2011/03/08 2011/03/09 2011/03/10 2011/03/11 2011/03/13 2011/03/14 2011/03/15 2011/03/16 2011/03/17 2011/03/18 2011/03/19 2011/03/20 2011/03/21 2011/03/22 2011/03/23 2011/03/24 2011/03/25 2011/03/26 2011/03/27 2011/03/28 2011/03/29 2011/03/30 2011/03/31
2011/04/01 2011/04/02 2011/04/03 2011/04/04 2011/04/05 2011/04/06 2011/04/07 2011/04/08 2011/04/09 2011/04/10 2011/04/11 2011/04/12 2011/04/13 2011/04/14 2011/04/15 2011/04/16 2011/04/17 2011/04/18 2011/04/19 2011/04/20 2011/04/21 2011/04/22 2011/04/23 2011/04/24 2011/04/25 2011/04/26 2011/04/27 2011/04/28 2011/04/29 2011/04/30
2011/05/01 2011/05/02 2011/05/03 2011/05/04 2011/05/05 2011/05/06 2011/05/07 2011/05/08 2011/05/09 2011/05/10 2011/05/11 2011/05/12 2011/05/13 2011/05/14 2011/05/15 2011/05/16 2011/05/17 2011/05/18 2011/05/19 2011/05/20 2011/05/21 2011/05/22 2011/05/23 2011/05/24 2011/05/25 2011/05/26 2011/05/27 2011/05/28 2011/05/29 2011/05/30 2011/05/31
2011/06/01 2011/06/02 2011/06/03 2011/06/04 2011/06/05 2011/06/06 2011/06/07 2011/06/08 2011/06/09 2011/06/10 2011/06/11 2011/06/12 2011/06/13 2011/06/14 2011/06/15 2011/06/16 2011/06/17 2011/06/18 2011/06/19 2011/06/20 2011/06/21 2011/06/22 2011/06/23 2011/06/24 2011/06/25 2011/06/26 2011/06/27 2011/06/28 2011/06/29 2011/06/30
2011/07/01 2011/07/02 2011/07/04 2011/07/05 2011/07/06 2011/07/07 2011/07/08 2011/07/10 2011/07/11 2011/07/12 2011/07/13 2011/07/14 2011/07/15 2011/07/16 2011/07/17 2011/07/18 2011/07/19 2011/07/20 2011/07/21 2011/07/22 2011/07/23 2011/07/25 2011/07/27 2011/07/28 2011/07/29 2011/07/31
2011/08/01 2011/08/02 2011/08/03 2011/08/05 2011/08/06 2011/08/07 2011/08/08 2011/08/09 2011/08/10 2011/08/11 2011/08/12 2011/08/13 2011/08/15 2011/08/16 2011/08/17 2011/08/18 2011/08/19 2011/08/21 2011/08/22 2011/08/23 2011/08/24

### Browse by creation date

66 72 73 75 79 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 00 01 02 03 04 05 06 07 08 09 10
1966/12
1972/02 1972/03 1972/08
1973/04 1973/10
1975/03
1979/08
1985/01 1985/02 1985/03 1985/05 1985/06 1985/10
1986/02 1986/05 1986/08 1986/09 1986/11 1986/12
1987/04 1987/06 1987/09 1987/12
1988/01 1988/03 1988/04 1988/07 1988/08 1988/09 1988/10 1988/12
1989/01 1989/03 1989/04 1989/06 1989/09 1989/12
1990/01 1990/02 1990/03 1990/07 1990/08 1990/10 1990/11
1991/01 1991/05 1991/06 1991/07 1991/08 1991/11
1992/01 1992/03 1992/06 1992/09 1992/11 1992/12
1993/01 1993/02 1993/04 1993/07 1993/10 1993/12
1994/05 1994/08 1994/11 1994/12
1995/01 1995/04 1995/06 1995/08 1995/09 1995/10 1995/11
1996/07 1996/08 1996/09 1996/11
1997/01 1997/02 1997/03 1997/05 1997/06 1997/08 1997/10 1997/11 1997/12
1998/05 1998/07 1998/08 1998/12
1999/01 1999/09 1999/10 1999/11 1999/12
2000/04 2000/05 2000/06 2000/09 2000/11 2000/12
2001/02 2001/03 2001/04 2001/05 2001/06 2001/07 2001/08 2001/09 2001/10 2001/11 2001/12
2002/01 2002/02 2002/03 2002/04 2002/05 2002/06 2002/07 2002/08 2002/09 2002/10 2002/11 2002/12
2003/01 2003/02 2003/03 2003/04 2003/05 2003/06 2003/07 2003/08 2003/09 2003/10 2003/11 2003/12
2004/01 2004/02 2004/03 2004/04 2004/05 2004/06 2004/07 2004/08 2004/09 2004/10 2004/11 2004/12
2005/01 2005/02 2005/03 2005/04 2005/05 2005/06 2005/07 2005/08 2005/09 2005/10 2005/11 2005/12
2006/01 2006/02 2006/03 2006/04 2006/05 2006/06 2006/07 2006/08 2006/09 2006/10 2006/11 2006/12
2007/01 2007/02 2007/03 2007/04 2007/05 2007/06 2007/07 2007/08 2007/09 2007/10 2007/11 2007/12
2008/01 2008/02 2008/03 2008/04 2008/05 2008/06 2008/07 2008/08 2008/09 2008/10 2008/11 2008/12
2009/01 2009/02 2009/03 2009/04 2009/05 2009/06 2009/07 2009/08 2009/09 2009/10 2009/11 2009/12
2010/01 2010/02

### Browse by origin

A B C D F G H I J K L M N O P Q R S T U V W Y Z
Embassy Athens Embassy Asuncion Embassy Astana Embassy Asmara Embassy Ashgabat Embassy Apia Embassy Antananarivo Embassy Ankara Embassy Amman Embassy Algiers Embassy Addis Ababa Embassy Accra Embassy Abuja Embassy Abu Dhabi Embassy Abidjan Consulate Auckland Consulate Amsterdam Consulate Alexandria Consulate Adana American Institute Taiwan, Taipei
Embasy Bonn Embassy Bujumbura Embassy Buenos Aires Embassy Budapest Embassy Bucharest Embassy Brussels Embassy Bridgetown Embassy Brazzaville Embassy Bratislava Embassy Brasilia Embassy Bogota Embassy Bishkek Embassy Bern Embassy Berlin Embassy Belmopan Embassy Belgrade Embassy Beirut Embassy Beijing Embassy Banjul Embassy Bangui Embassy Bangkok Embassy Bandar Seri Begawan Embassy Bamako Embassy Baku Embassy Baghdad Consulate Belfast Consulate Barcelona
Embassy Cotonou Embassy Copenhagen Embassy Conakry Embassy Colombo Embassy Chisinau Embassy Caracas Embassy Canberra Embassy Cairo Consulate Curacao Consulate Ciudad Juarez Consulate Chiang Mai Consulate Chennai Consulate Chengdu Consulate Casablanca Consulate Cape Town Consulate Calgary
Embassy Dushanbe Embassy Dublin Embassy Doha Embassy Djibouti Embassy Dili Embassy Dhaka Embassy Dar Es Salaam Embassy Damascus Embassy Dakar DIR FSINFATC Consulate Dusseldorf Consulate Durban Consulate Dubai Consulate Dhahran
Embassy Freetown Consulate Fukuoka Consulate Frankfurt
Embassy Guatemala Embassy Grenada Embassy Georgetown Embassy Gaborone Consulate Guayaquil Consulate Guangzhou Consulate Guadalajara
Embassy Helsinki Embassy Harare Embassy Hanoi Consulate Hong Kong Consulate Ho Chi Minh City Consulate Hermosillo Consulate Hamilton Consulate Hamburg Consulate Halifax
Iran RPO Dubai Embassy Islamabad Consulate Izmir Consulate Istanbul
Embassy Jakarta Consulate Johannesburg Consulate Jerusalem Consulate Jeddah
Embassy Kyiv Embassy Kuwait Embassy Kuala Lumpur Embassy Kolonia Embassy Kinshasa Embassy Kingston Embassy Kigali Embassy Khartoum Embassy Kathmandu Embassy Kampala Embassy Kabul Consulate Krakow Consulate Kolkata Consulate Karachi
Embassy Luxembourg Embassy Lusaka Embassy Luanda Embassy London Embassy Lome Embassy Ljubljana Embassy Lisbon Embassy Lima Embassy Lilongwe Embassy Libreville Embassy La Paz Consulate Leipzig Consulate Lahore Consulate Lagos
Mission USOSCE Mission USNATO Mission UNESCO Mission Geneva Embassy Muscat Embassy Moscow Embassy Montevideo Embassy Monrovia Embassy Mogadishu Embassy Minsk Embassy Mexico Embassy Mbabane Embassy Maseru Embassy Maputo Embassy Manila Embassy Manama Embassy Managua Embassy Malabo Embassy Madrid Consulate Munich Consulate Mumbai Consulate Montreal Consulate Monterrey Consulate Milan Consulate Merida Consulate Melbourne Consulate Matamoros Consulate Marseille
Embassy Nouakchott Embassy Nicosia Embassy Niamey Embassy New Delhi Embassy Ndjamena Embassy Nassau Embassy Nairobi Consulate Nuevo Laredo Consulate Naples Consulate Naha Consulate Nagoya
Embassy Ouagadougou Embassy Ottawa Embassy Oslo
Embassy Pristina Embassy Pretoria Embassy Praia Embassy Prague Embassy Port Of Spain Embassy Port Moresby Embassy Port Louis Embassy Port Au Prince Embassy Podgorica Embassy Phnom Penh Embassy Paris Embassy Paramaribo Embassy Panama Consulate Peshawar
Embassy Quito Consulate Quebec
REO Hillah REO Basrah Embassy Rome Embassy Riyadh Embassy Riga Embassy Reykjavik Embassy Rangoon Embassy Rabat Consulate Rio De Janeiro Consulate Recife
Secretary of State Embassy Suva Embassy Stockholm Embassy Sofia Embassy Skopje Embassy Singapore Embassy Seoul Embassy Sarajevo Embassy Santo Domingo Embassy Santiago Embassy Sanaa Embassy San Salvador Embassy San Jose Consulate Surabaya Consulate Strasbourg Consulate St Petersburg Consulate Shenyang Consulate Shanghai Consulate Sapporo Consulate Sao Paulo
Embassy Tunis Embassy Tripoli Embassy Tokyo Embassy Tirana Embassy The Hague Embassy Tel Aviv Embassy Tehran Embassy Tegucigalpa Embassy Tbilisi Embassy Tashkent Embassy Tallinn Consulate Toronto Consulate Tijuana Consulate Thessaloniki
USUN New York USMISSION USTR GENEVA USEU Brussels US Office Almaty US Mission Geneva US Mission CD Geneva US Interests Section Havana US Delegation, Secretary UNVIE UN Rome Embassy Ulaanbaatar
Embassy Vilnius Embassy Vientiane Embassy Vienna Embassy Vatican Embassy Valletta Consulate Vladivostok Consulate Vancouver
Embassy Windhoek Embassy Wellington Embassy Warsaw
Embassy Yerevan Embassy Yaounde Consulate Yekaterinburg
Embassy Zagreb

### Browse by tag

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
AMGT ASEC AEMR AR APECO AU AORC ADANA AJ AF AFIN AMED AS AM ABLD AFFAIRS AMB APER ACOA AND AA AE AADP AID AO AL AG AORD ADM AINF AINT ASEAN AORG ABT APEC AY ASUP ARF AGOA AVIAN ATRN ANET AGIT ASECVE ABUD AODE ALOW ADB AN ADPM ASPA ARABL AFSN AZ AC AIAG AFSI ASCE ASIG ACABQ ADIP AFGHANISTAN AROC ADCO ACOTA ANARCHISTS AMEDCASCKFLO AK ARABBL ASCH ANTITERRORISM AGRICULTURE AOCR ARR ASSEMBLY AORCYM AFPK ACKM AGMT AEC APRC AIN AFPREL ASFC ASECTH AFSA AINR AOPC AFAF AFARI AX ASECAF ASECAFIN AT AFZAL APCS AGAO AIT ARCH AEMRASECCASCKFLOMARRPRELPINRAMGTJMXL AMEX ARM AQ ATFN AMBASSADOR AORCD AVIATION ARAS AINFCY ACBAQ AOPR AREP AOIC ASEX ASEK AER AGR AMCT AVERY APR AEMRS AFU AMG ATPDEA ASECKFRDCVISKIRFPHUMSMIGEG AORL ACS AMCHAMS AECL AUC ACAO
BA BR BB BG BEXP BY BRUSSELS BU BD BTIO BK BL BE BMGT BO BM BX BN BWC BBSR BTT BC BH BILAT BUSH BHUM BT BTC BMENA BOND BAIO BP BF BRPA BURNS BUT BBG BCW BOEHNER BOL BASHAR BIDEN BFIN BZ BEXPC BTIU
CPAS CA CASC CS CBW CIDA CO CODEL CI CROS CU CH CWC CMGT CVIS CDG CTR CG CF CHIEF CJAN CBSA CE CY CB CW CM CHR CD COE CV COUNTER CT CN CPUOS CTERR CVR CVPR CDC COUNTRY CLEARANCE CONS COM CACS CR CONTROLS CAN CACM COMMERCE CAMBODIA CFIS COUNTERTERRORISM CITES CONDOLEEZZA CZ CTBT CEN CLINTON CFED CARC CTM CARICOM CSW CICTE CYPRUS CBE CMGMT CARSON CWCM CIVS COUNTRYCLEARANCE CENTCOM CAPC COPUOS CKGR CITEL CQ CITT CIC CARIB CVIC CAFTA CVISU CDB CEDAW CNC CJUS COMMAND CENTER COL CAJC CONSULAR CLMT CBC CIA CNARC CIS CEUDA CHINA CAC CL
DR DJ DEMOCRATIC DEMARCHE DOMESTIC DISENGAGEMENT DB DA DHS DAO DCM DAVID DO DEAX DEFENSE DEA DTRO DPRK DOC DTRA DK DAC DOD DRL DRC DCG DE DOT DEPT DOE DS DKEM
ECON ETTC EFIS ETRD EC EMIN EAGR EAID EFIN EUN ECIN EG EWWT EINV ENRG ELAB EPET EIND EN EAIR EUMEM ECPS ES EI ELTN ET EZ EU ER EINT ENGR ECONOMIC ENIV EFTA ETRN EMS EUREM EPA ESTH EEB EET ENV EAG EXIM ECTRD ELNT ENVIRONMENT ECA EAP EINDIR ETR ECONOMY ETRC ELECTIONS EICN EXPORT EARG EGHG EID ETRO EINF EAIDHO ECIP EENV EURM EPEC ERNG ENERG EIAD EXBS ED EREL ELAM EK EWT ENGRD EDEV ECE ENGY EXIMOPIC ETRDEC ECCT EUR ENRGPARMOTRASENVKGHGPGOVECONTSPLEAID EFI ECOSOC EXTERNAL ESCAP ETCC EENG ERA ENRD ECLAC ETRAD EBRD ENVR ECONENRG ELTNSNAR ELAP EPIT EDUC EAIDXMXAXBXFFR EETC EIVN EDRC EGOV ETRA EAIDRW ETRDEINVECINPGOVCS ESA ETRDGK ENVI ELN EPRT EPTED ERTD EUM EAIDS EFINECONEAIDUNGAGM EDU EV EAIDAF EDA EPREL EINVEFIN EAGER ETMIN EUCOM ECCP EIDN EINVKSCA ENNP EFINECONCS ETC EAIRASECCASCID EINN ETRP ECONOMICS ENERGY EIAR EINDETRD ECONEFIN EURN ETRDEINVTINTCS EFIM ETIO EATO EIPR EINVETC ETTD ETDR EIQ ECONCS ENRGIZ EAIG ENTG EUC ERD EINVECONSENVCSJA EEPET EUNCH ESENV ECINECONCS ETRDECONWTOCS ECUN
FR FI FOREIGN FARM FIR FAO FK FARC FAS FJ FREEDOM FAC FINANCE FBI FTAA FM FCS FAA FORCE FDA FTA FT FCSC FMGT FINR FIN FDIC FOR FOI FO FMLN FISO
GM GERARD GT GA GG GR GTIP GH GZ GE GB GY GAZA GJ GEORGE GOI GCC GMUS GI GLOBAL GV GC GL GOV GKGIC GF GWI GIPNC GUTIERREZ GTMO GANGS GAERC GUILLERMO GASPAR
HR HA HYMPSK HO HK HUMAN HU HN HHS HURI HUD HUMRIT HUMANITARIAN HUMANR HL HSTC HILLARY HCOPIL HADLEY HOURANI HI HUM HEBRON HUMOR
IZ IN IAEA IS IMO ILO IR IC IT ITU ID IV IMF IBRD IWC ICAO ICRC INF IO IPR ISO IK ISRAELI IQ ICES IDB INFLUENZA IRAQI ISCON IGAD IRAN ITALY IRAQ ICTY ICTR ITPGOV ITALIAN IQNV IADB INTERNAL INMARSAT IRDB ILC INCB INRB ICJ ISRAEL INR IEA ISPA ICCAT IOM ITRD IHO IL IFAD ITRA IDLI ISCA INL INRA INTELSAT ISAF ISPL IRS IEF ITER INDO IIP IND IEFIN IACI IAHRC INNP IA INTERPOL IFIN ISSUES IZPREL IRAJ IF ITPHUM ITA IP IRPE IDA ISLAMISTS ITF INRO IBET IDP IRC
JA JO JM JP JCIC JOSEPH JAPAN JOHN JE JS JUS JN JOHNNIE JKUS JAMES JML JIMENEZ JK
KMDR KPAO KOMC KNNP KFLO KDEM KSUM KIPR KFLU KE KCRM KJUS KAWC KZ KSCA KDRG KCOR KGHG KPAL KTIP KMCA KCRS KPKO KOLY KRVC KVPR KG KWBG KTER KS KN KSPR KWMN KV KTFN KFRD KU KSTC KSTH KISL KGIC KSEP KFIN KTEX KTIA KUNR KCMR KCIP KMOC KTDB KBIO KBCT KMPI KSAF KACT KFEM KPRV KPWR KIRC KCFE KRIM KHIV KHLS KVIR KNNNP KCEM KLIG KIRF KNUP KSAC KNUC KPGOV KTDD KIDE KOMS KLFU KNNC KMFO KSEO KJRE KJUST KMRS KSRE KGIT KPIR KPOA KUWAIT KIVP KICC KSCS KPOL KSEAO KRCM KSCI KNAP KGLB KICA KCUL KPRM KFSC KQ KPOP KPFO KPALAOIS KREC KBWG KR KTTB KNAR KCOM KESS KINR KOCI KWN KCSY KREL KTBT KFTN KW KRFD KFLOA KHDP KNEP KIND KHUM KSKN KOMO KDRL KTFIN KSOC KPO KGIV KSTCPL KSI KPRP KFPC KNNB KNDP KICCPUR KFRDCVISCMGTCASCKOCIASECPHUMSMIGEG KDMR KFCE KIMMITT KMCC KMNP KSEC KOMCSG KGCC KRAD KCRP KAUST KWAWC KCHG KRDP KPAS KTIAPARM KPAOPREL KWGB KIRP KMIG KLAB KSEI KHSA KNPP KPAONZ KWWW KGHA KY KCRIM KCRCM KGCN KPLS KIIP KPAOY KTRD KTAO KJU KBTS KWAC KFIU KNNO KPAI KILS KPA KRCS KWBGSY KNPPIS KNNPMNUC KNPT KERG KLTN KPREL KTLA KO KAWK KVRP KAID KX KENV KWCI KNPR KCFC KNEI KFTFN KTFM KCERS KDEMAF KMEPI KEMS KBTR KEDU KIRL KNNR KMPT KPDD KPIN KDEV KFRP KTBD KMSG KWWMN KWBC KA KOM KWNM KFRDKIRFCVISCMGTKOCIASECPHUMSMIGEG KRGY KNNF KICR KIFR KWMNCS KPAK KDDG KCGC KID KNSD KMPF KWMM
LY LE LABOR LH LI LO LN LT LAB LTTE LU LG LA LB LOTT LVPR LAW LAURA LS LOVE LR LOG
MARR MX MASS MOPS MNUC MCAP MTCRE MRCRE MTRE MASC MY MK MG MU MILI MO MZ MEPP MCC MEDIA MOPPS MI MAS MW MP MEPN MV MD MR MC MCA MT MIL MARITIME MOPSGRPARM MAAR MOOPS ML MA MN MNUCPTEREZ MTCR MUNC MPOS MONUC MGMT MURRAY MACP MINUSTAH MCCONNELL MGT MNUR MF MEPI MOHAMMAD MAR MAPP MNU MFA MTS MLS MEETINGS MERCOSUR MED MNVC MIK MBM MILITARY MAPS MARAD MDC MACEDONIA MASSMNUC MUCN MQADHAFI MPS
NZ NATO NI NO NU NG NL NPT NS NA NP NASA NSF NEA NANCY NSG NRR NATIONAL NMNUC NC NSC NAS NARC NELSON NATEU NDP NIH NK NIPP NR NERG NSSP NE NTDB NT NEGROPONTE NGO NATOIRAQ NAR NZUS NCCC NH NAFTA NEW NRG NUIN NOVO NATOPREL NV NICHOLAS NPA NSFO NW NORAD NPG NOAA
OPRC OPDC OTRA OECD OVIP OREP ODC OIIP OAS OSCE OPIC OMS OFDP OFDA OEXC OPCW OIE OSCI OM OPAD ODPC OIC ODIP OPPI ORA OCEA OREG OMIG OFFICIALS OSAC OEXP OPEC OFPD OAU OCII OIL OVIPPRELUNGANU OSHA OPCD OPCR OF OFDPQIS OSIC OHUM OTR OBSP OGAC OESC OVP ON OES OTAR OCS
PREL PGOV PARM PINR PHUM PM PREF PTER PK PINS PBIO PHSA PE PBTS PA PL POL PAK POV POLITICS POLICY PO PRELTBIOBA PKO PIN PNAT PU PGOVPREL PALESTINIAN PTERPGOV PELOSI PAS PP PTEL PROP PRELAF PRHUM PRE PUNE PIRF PVOV PROG PERSONS PROV PKK PRGOV PH PLAB PDEM PCI PRL PRM PINSO PERM PETR PPAO PERL PBS PETERS PRELBR PCON POLITICAL PMIL POLM PKPA PNUM PLO PTERM PJUS PARMP PNIR PHUMKPAL PG PREZ PGIC PAO PROTECTION PRELPK PGOVENRG PATTY PSOC PARTIES PGOVEAIDUKNOSWGMHUCANLLHFRSPITNZ PMIG PAIGH PARK PETER PHUS PKPO PGOVECON POUS PMAR PWBG PAR PGOVGM PHUH PTE PY POLUN PDOV PGOVSOCI PGOVPM PRELEVU PGOR PBTSRU PHUMA PHUMR PPD PGV PRAM PARMS PINL PSI PKPAL PPA PTERE PGOF PINO PREO PHAS PAC PRESL PORG PS PGVO PKFK PSOE PEPR PINT PRELP PREFA PNG PTBS PFOR PGOVLO PHUMBA PREK PHJM POLINT PGOVE PHALANAGE PARTY PECON PEACE PROCESS PLN PEDRO PF PGPV PCUL PGGV PSA PGOVSMIGKCRMKWMNPHUMCVISKFRDCA PGIV PHUMPREL POGOV PEL PBT PAMQ PINF PSEPC POSTS PAHO PHUMPGOV PGOC PNR
QA QI QT QM QADRI
RS RP RU RW RFE RCMP RIGHTSPOLMIL REFORM RO ROW ROBERT REACTION REPORT REGION RELATIONS RAY ROBERTG RIGHTS RM RATIFICATION RREL RBI RICE ROOD REL RODHAM RGY RUEHZO RELIGIOUS RELFREE RUEUN RELAM RSP RF REO REGIONAL RUPREL RI REMON RPEL RSO
SCUL SENV SOCI SZ SNAR SO SP SU SY SI SMIG SYR SA SW SF SR SYRIA SNARM START SPECIALIST SG SNIG SCI SGWI SE SIPDIS SANC SELAB SN SETTLEMENTS SCIENCE SENVENV SENS SPCE SPAS SECURITY SENC SOCIETY SOSI SENVEAGREAIDTBIOECONSOCIXR SEN SPECI ST SL SENVCASCEAIDID SC SECRETARY STR SNA SOCIS SADC SEP SK SHUM SYAI SMIL STEPHEN SNRV SKCA SENSITIVE SECI SCUD SCRM SGNV SECTOR SAARC SENVSXE SWMN STEINBERG SOPN SOCR SCRS SWE SARS SNARIZ SUDAN SENVQGR SAN SM SFNV SSA SPCVIS SOFA SCULKPAOECONTU SENVKGHG SHI SEVN SH SNARCS SNARN SIPRS
TBIO TW TRGY TSPA TU TPHY TI TX TH TIP TSPL TNGD TZ TS TC TK TURKEY TERRORISM TPSL TINT TRSY TERFIN TPP TT TECHNOLOGY TE TAGS TRAFFICKING TJ TN TO TD TP TREATY TR TA TIO TECH TF TRAD TNDG TWI TPSA TWL TAUSCHER TRBY TL TV THPY TSPAM TREL TRT TNAR TFIN TWCH THOMMA THOMAS TERROR TRY TBID
UK UNESCO UNSC UNGA UN US UZ USEU UG UP UNAUS UNMIK USTR UY USUN UNEP UNDC UV UNPUOS UNSCR USAID UNODC UNRCR UNHCR UNDP UNCRIME UA UNHRC UNRWA UNO UNCND UNCHR USAU UNICEF USPS UNOMIG UNESCOSCULPRELPHUMKPALCUIRXFVEKV UR UNFICYP UNCITRAL UNAMA UNVIE USTDA USNC UNCSD USCC UNEF UNGAPL USSC UNMIC UNTAC UNCLASSIFIED USDA UNCTAD USGS UNFPA UNSE USOAS UE UAE UNCHS UNDESCO UNC UNSCS UKXG UNGACG UNHR UNBRO UNCHC UNFCYP UNIDROIT
VE VM VT VZ VEPREL VN VEN VTPREL VC VTEG VOA VTEAID VTIZ VISIT VENZ VAT VI
WHTI WIPO WTRO WHO WTO WMO WFP WEET WS WE WA WHA WBG WILLIAM WI WSIS WCL WEBZ WZ WW WWBG WMD WWT WMN WWARD WITH WTRQ WCO WEU WB WBEG
XA XX XW XK XL XM XS XF XH XB XG XT XR XY XO XD XV XI XE XC XJ XU XZ XQ XP XFNEA XTAG
YM YI YE YMOEXC YL YMCS
ZU ZI ZM ZK ZP ZOELLICK ZR ZF ZA ZL ZO ZJ ZANU ZB ZN ZH ZT ZFR ZEALAND ZXA

### Browse by classification

CONFIDENTIAL CONFIDENTIAL//NOFORN SECRET SECRET//NOFORN UNCLASSIFIED UNCLASSIFIED//FOR OFFICIAL USE ONLY

### Community resources

Follow us on Twitter Check our Reddit Twitter this Digg this page Contact us on IRC

courage is contagious

### Viewing cable 04ANKARA1157, Pharmaceuticals Update: Multinationals

If you are new to these pages, please read an introduction on the structure of a cable as well as how to discuss them with others. See also the FAQs
Understanding cables
Every cable message consists of three parts:

- The top box shows each cables unique reference number, when and by whom it originally was sent, and what its initial classification was.
- The middle box contains the header information that is associated with the cable. It includes information about the receiver(s) as well as a general subject.
- The bottom box presents the body of the cable. The opening can contain a more specific subject, references to other cables (browse by origin to find them) or additional comment. This is followed by the main contents of the cable: a summary, a collection of specific topics and a comment section.

To understand the justification used for the classification of each cable, please use this WikiSource article as reference.
Discussing cables
If you find meaningful or important information in a cable, please link directly to its unique reference number. Linking to a specific paragraph in the body of a cable is also possible by copying the appropriate link (to be found at theparagraph symbol). Please mark messages for social networking services like Twitter with the hash tags #cablegate and a hash containing the reference ID e.g. #04ANKARA1157.

Reference ID | Created | Released | Classification | Origin
--- | --- | --- | --- | ---
04ANKARA1157 | 2004-02-27 11:34 | 2011-08-24 01:00 | UNCLASSIFIED//FOR OFFICIAL USE ONLY | Embassy Ankara

`

    This record is a partial extract of the original cable. The full text of the original cable is not available.

` `

    UNCLAS SECTION 01 OF 05 ANKARA 001157

    SIPDIS

    DEPT FOR EB/TPP/MTA/IPC - SWILSON/JURBAN AND EUR/SE
    DEPT PASS USTR FOR LERRION/BPECK
    DEPT PASS LIBRARY OF CONGRESS
    DEPT PASS USPTO FOR ELAINE WU
    USDOC FOR ITA/MAC/DDEFALCO

    SENSITIVE

    E.O. 12958: N/A
    TAGS: ETRD KIPR TU
    SUBJECT: Pharmaceuticals Update:  Multinationals
    Threatened by New Pricing Decree

    Ref:  Ankara 977 and previous

    Summary
    -------

    ¶1. (SBU) U.S. companies have complained that a new GOT
    pricing caps threaten the commercial viability of many
    of their product lines, and could lead them to delay or
    suspend the launch of new pharmaceuticals in Turkey.  In
    a letter to USTR, the Foreign Trade Undersecretary
    maintains that the GOT views data exclusivity as an EU
    Customs Union obligation rather than a WTO TRIPS
    requirement, and that this policy will be introduced
    with an unspecified transition period.  The GOT's
    Council of State rendered a decision limiting the
    application of "cheapest generic" reimbursement policy
    in the state pension fund.  Embassy requests guidance on
    the pricing decree, and urges Washington agencies to
    pursue sustained engagement with the GOT on intellectual
    property and other WTO issues affecting the
    pharmaceuticals sector.  End Summary.

    New Price System A Blow to Research-Based Firms
    --------------------------------------------- --

    ¶2. (U) At a February 20 briefing for the Ambassador,
    U.S. companies expressed serious concern with a February
    14 pricing decree.  The decree, which is already in
    force, limits pharmaceuticals prices in Turkey to a
    maximum of 90 percent of the average of the lowest two
    prices prevailing in a group of five European countries.
    While the measure does not appear to address any
    intellectual property issues, it may contain WTO-
    inconsistent provisions allowing higher prices for
    domestically-produced generic drugs, and does not set
    objective pricing criteria or remedy mechanisms for
    companies applying under the decree (reproduced in para
    9).

    ¶3. (U) Research-based companies had pressed for changes
    to the previous pricing system, which applied
    discriminatory price limits on imported pharmaceuticals,
    and had even suggested some forms of reference pricing.
    While the new system eliminates many of those
    provisions, research-based companies have told us that
    the new system will render sale of some medicines
    unprofitable, and could lead to delay or suspension in
    the launch of new molecules in Turkey.  AIFD, the
    Turkish research-based pharmaceuticals association, has
    written to the Prime Minister to register its concerns
    with the decree.

    ¶4. (SBU) Econoff raised U.S. company concerns with
    Hayriye Mihcak, the Health Ministry's Director General
    for Pharmaceuticals, Dilek Emil, the Treasury
    Undersecretariat's Deputy Director General for Foreign
    Investment, and Husnu Dilemre, Foreign Trade's Deputy
    Director General for Multilateral Agreements.  All
    expressed some surprise that research-based companies
    did not consider the decree an improvement over the
    previous pricing system.  Foreign Trade told us that the
    Turkish decree was modeled on Portugese and Spanish drug
    pricing systems.

    Data Exclusivity
    ----------------

    ¶5. (SBU) The GOT has not made an announcement on data
    exclusivity, though Mihcak told us that the Government
    planned to make an announcement on this by the end of
    March.  Dilemre also said that a decision on data
    exclusivity would be announced soon, but emphasized that
    Turkey viewed this as an EU Customs Union obligation
    rather than a WTO TRIPS requirement.  In a February 11
    letter to A/USTR Novelli (reproduced in para 10),
    Foreign Trade Undersecretary Tuncer Kayalar also made
    these points, but argued that Turkey would need a
    transition period for implementation.

    Legal Challenge on Reimbursement Policy
    ---------------------------------------

    ¶6. (U) In January 2004, the Council of State (Danistay)
    issued a ruling restricting application of the "cheapest
    generic" pharmaceuticals reimbursement policy for the
    GOT's pension fund.  The decision, a preliminary
    injunction, calls for the GOT to stop implementation,
    within 30 days, of "cheapest generic" reference pricing.
    However, industry sources have said that the injunction
    is likely to be overturned as the case moves through the
    courts.  The Danistay also limited reimbursement of
    generics to those which the GOT has certified as
    "bioequivalent" with the brand name molecule.  While
    research-based companies have welcomed the decision, the
    impact will be limited:  industry sources relate that
    there is now a bioequivalent generic for most original
    drugs.

    Comment/Action Request
    ----------------------

    ¶7. (SBU) Research-based industry is alarmed by the new
    pricing decree, though its concerns seem to lie more
    with the pricing formula for brand name drugs than with
    the parts of the decree (generic pricing, transparency)
    that could be WTO-inconsistent.  Embassy requests
    Washington agencies' guidance on whether to advocate for
    change in the pricing formula.

    ¶8. (SBU) As noted reftel, elevating Turkey in the
    Special 301 Watch List system, combined with sustained
    Washington engagement, is our best hope for prodding the
    GOT to action on data exclusivity and WTO-inconsistent
    practices.  We understand that Commerce A/S Lash and
    Senator Lugar plan to write to top GOT officials on
    pharmaceuticals issues.  Embassy continues to recommend
    that Washington agencies also consider dispatching an
    interagency IPR delegation to Ankara, and sending
    additional high-level correspondence on these issues,
    and particularly to rebut the GOT's position that the
    TRIPS Agreement does not require data exclusivity.

    ¶9. (U) Begin Text - AIFD Translation of GOT Pricing
    Decree:

    Decision No: 2004/6781
    It has been decided to enforce the attached "Decision
    Regarding the Pricing of Medicinal Product for Human
    Use" upon the letter dated 21/1/2004 and 003149 of the
    Ministry of Health, by the Council of Ministers on
    6/2/2004.

    Decision Regarding the Pricing of Medicinal Products for
    Human Use

    Article 1 - In accordance with "the Law no. 1262 on
    Pharmaceutical and Medicinal Products" and "the
    Fundamental Law no. 3359 on Healthcare Services", the
    Ministry of Health (the Ministry) shall determine the
    maximum prices by adopting the necessary measures that
    will be taken to ensure the affordability of medicinal
    products for human use (products).  Companies may
    request prices below the maximum price. The price
    approved by the Ministry of Health shall be in effect as
    of the date of its approval.

    Article 2 - The Ministry of Finance shall be authorized
    to investigate the suitability of these prices to the
    principles set forth in this Decision.

    Article 3- The maximum price of original products,
    excluding VAT, shall be determined as follows: 2
    reference countries with the cheapest prices of the
    product for which a price is to be determined in Turkey
    shall be selected out of 5 countries, namely France,
    Italy, Spain, Portugal and Greece in the year 2004 and
    to be deemed as suitable among the European Union (EU)
    countries by the Ministry; the retailer sale price of
    the product shall be determined by taking as basis
    maximum 90 percent of the average ex-factory price
    (sales price to the wholesalers calculated by deducting
    pharmacy and wholesaler profits from the retailer sale
    price) of these 2 reference countries and by adding the
    profit rates of wholesalers and pharmacies to be
    calculated in accordance with article 10. Should the ex-
    factory price in the country from where the product is
    imported be lower than the determined reference price,
    the profit rates of wholesalers and pharmacies shall be
    added to the price in the country from where it is
    imported.

    Article 4 - The retailer sales price of generic
    products, excluding VAT, shall be determined by taking
    as basis maximum 70 percent of the average of the ex-
    factory sales price of the original drugs of these
    products, calculated in accordance with article 3 and
    adding the profit rates of wholesalers and pharmacies.
    Yet, the maximum rate may be increased to 80 percent in
    case it is documented that locally manufactured raw
    materials have been utilized as the active ingredient of
    the drug in the production of generic products. In case
    the ex-factory sales price in the country from where the
    product is imported, results to be lower than the price
    determined for the EU countries, the profit rates of the
    wholesaler and pharmacies shall be added to the price in
    the pertinent country.

    Article 5 - The price of the products not marketed
    outside Turkey and the products not marketed by the EU
    countries shall be determined by taking into
    consideration the principles and the cost factors set
    forth in articles 3 and 4, provided it does not surpass
    the price of similar products.

    Article 6 - The ex-factory price of the products packed
    for hospitals shall be determined by taking into
    consideration the principles and the cost factors set
    forth in articles 3 and 4, provided it remains at least
    10percent below the unit prices of the original
    products.

    Article 7 - A "Price Evaluation Commission" shall be
    established and convene on a quarterly basis upon the
    participation of the representatives of the Ministry of
    Finance, the State Planning Organization and the Turkish
    Treasury under the coordination of the Ministry of
    Health, in order to submit proposals  to the Ministry of
    Health for the increase, decrease, or freezing of the
    price of medicinal products. In case of a change of more
    than 5percent in the foreign exchange rate within a
    minimum period of 30 days, the Price Evaluation
    Commission shall convene on an extraordinary basis, upon
    the invitation of the Ministry of Health to re-evaluate
    the prices of products. The secretarial services of the
    commission in question shall be executed by the Ministry
    of Health.

    A "Reimbursement Commission" shall be established and
    convene once every 6 months upon the participation of
    the representatives of the Ministry of Health, the State
    Planning Organization and the Turkish Treasury, the
    Social Insurance Institution, Emekli Sandygy and Bad-Kur
    and upon consulting the views of civil society
    organizations, under the coordination of the Ministry of
    Health, in order to submit proposals to the pertinent
    ministries. The secretarial services of the commission
    in question shall be executed by the Ministry of Health.

    Article  8 - Product manufacturers and importers shall
    be obligated to document that their products are
    original or generic. Manufacturers and importers shall
    be obligated to submit to the Ministry the ex-factory
    prices in the reference countries together with their
    requests for obtaining, increasing or decreasing a
    price. The TL equivalent of the prices determined shall
    be calculated upon the foreign exchange sales rate of
    the Central Bank of the Turkish Republic. The price
    which is deemed suitable shall be approved by the
    Ministry within 10 working days. The justification for a
    price which is not deemed suitable shall be communicated
    by the Ministry to the concerned company within 10
    working days. The pricing transaction shall be executed
    within 90 working days upon the submission of the valid
    documentation by the concerned company. This period may
    be extended by 60 working days in case of accumulation
    of applications and in periods of heavy workload. In
    case of failure of the concerned companies to submit
    their valid documents, the price determined by the
    Ministry shall be retained valid.

    Article 9 - In case of a decrease of 5percent or more in
    the price of the original product in the reference
    countries, the company manufacturing or importing the
    product shall be obligated to apply to the Ministry
    within 30 days to obtain a new price. A second degree
    withdrawal transaction shall be implemented on the
    products for it is determined by the Ministry that no
    such notification has been made and the registration
    shall be suspended for a period three times longer than
    the period in which no notification has been made,
    including 30 days. The suspension transaction shall be
    annulled by issuing the new price at the end of this
    period.

    Article 10- The wholesaler and pharmacy profit rates to
    be implemented when determining the retailer sales
    price of products in accordance with article 3 and 4,
    shall be determined in segments as follows, for both
    imported and local products:

    Out of the sales price to wholesalers/Wholesaler
    (Percent)/Pharmacy (Percent):

    Part up to/including 10 million TL: 9, 25
    Part between 10 - 50 million TL: 8, 24
    Part between 50 - 100 million TL: 7, 23
    Part between 100 - 200 million TL: 4, 16
    Part above 200 million TL: 2, 10

    The Ministry of Health shall be authorized to review
    these rates by taking into consideration the annual
    wholesale price index of chemical products of the State
    Statistics Institute of the former year and the
    allocation of the total sales of medicinal products in
    the last 3 years.

    Article 11 - Product manufacturers and importers are
    obligated to adhere to the principles set forth in this
    Decision.  Legal action within the pertinent
    legislation shall be taken against those in violation
    of these principles.

    Article 12 - The Ministry shall be authorized to issue
    notifications with regard to the implementation of this
    Decision.

    Article 13 - The Council of Ministers Decision dated
    6/2/2002, with no. 2002/4331 has been revoked.

    Temporary Article l- As of the publication date of this
    Decision, the prices of registered products shall be re-
    determined in accordance with the principles set forth
    in this Decision. The concerned companies shall apply to
    the Ministry upon having compiled the necessary
    documents in accordance with this Decision, within 45
    days as of the publication date of the Decision, in
    order to establish a basis for the determination of the
    new prices.  The registrations of the products for which
    no application is submitted within this period shall be
    suspended until the application date. The sales prices
    excluding VAT, to be determined in accordance with this
    article, shall not surpass the price in TL, excluding
    VAT, on the date of this Decision for local products,
    and the amount in TL, excluding VAT, corresponding to
    the foreign exchange sales rate of the Central Bank of
    the Turkish Republic, on the application date for the
    product for imported products.

    Temporary Article 2- The prices of imported products
    shall be re-determined ex-officio by the Ministry over
    the foreign exchange sales rate of the Central Bank of
    the Turkish Republic on the publication date of this
    Decision. The new prices shall be retained valid as of
    the approval date.

    Article 14- This Decision shall be enforced as of its
    publication date.

    Article 15- This Decision shall be executed by the
    Council of Ministers.

    End Text - AIFD Translation of GOT Pricing Decree.

    ¶10. (U) Begin Text - Foreign Trade U/S - USTR Letter

    February 11, 2004
    Ms. Catherine A. Novelli
    Assistant US-Trade Representative for
    Europe and the Mediterranean
    Dear Ms. Novelli,

    I would like to thank you for your letter dated January
    14, 2004 which has provided me with the opportunity to
    clarify the misconception about the compliance of
    Turkey's IPR legislation with the TRIPS Agreement.

    As you will recall, the WTO Members unanimously
    confirmed the consistency of Turkey's IPR legislation
    and implementations with the TRIPS Agreement at the
    TRIPS Council's meeting in Geneva on November 30, 2000.

    Besides, as referred in your letter, our authorities are
    working on a plan to introduce and implement rules and
    regulations regarding data exclusivity in
    pharmaceuticals in line with our commitments arising
    from the Customs Union with the EU.

    As you may appreciate, this plan will not only have
    negative impacts on the consumers and the current public
    health policies but on the generic industry as well.
    Therefore, the transition period turns out to be a
    necessity to offset to a certain extent the economic and
    social pressures and to avoid any further economic
    damages that would be recovered at a higher cost
    otherwise.

    On the other hand, I would like to note that my
    colleagues are doing their best to figure out an option
    that keeps the transition period as short as possible.
    At this point, supportive approaches from our trading
    partners will certainly contribute to the early
    conclusion of their studies.

    Expressing my best wishes and highest regards to you, I
    remain,

    Sincerely Yours,

    Tuncer Kayalar
    Undersecretary

    End Text Foreign Trade/USTR Letter.
    Edelman

`